Yair Granot
Vorstandsvorsitzender bei Curesign Ltd
Profil
Yair Granot is currently the Chief Executive Officer at Curesign Ltd.
Previously, he worked as the Chief Executive Officer & VP-Development at Silver Castle Holdings Ltd.
and as the Chief Technology Officer at Essence Healthcare Ltd.
He holds a doctorate degree from the University of California, Berkeley and a graduate degree from Tel-Aviv University.
Aktive Positionen von Yair Granot
Unternehmen | Position | Beginn |
---|---|---|
Curesign Ltd
Curesign Ltd Medical SpecialtiesHealth Technology Curesign Ltd is a medical device company based in Tel Aviv, Israel. The Israeli company aims to revolutionize cancer treatment by integrating advanced sensors with signal processing and big data tools to create a patient-specific treatment plan for each cancer patient. The company's product is currently in advanced stages of development and has shown successful results in preclinical studies. The CEO of the company is Yair Granot. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Yair Granot
Unternehmen | Position | Ende |
---|---|---|
Essence Healthcare Ltd. | Technik-/Wissenschafts-/F&E-Leiter | - |
SILVER CASTLE HOLDINGS LTD | Vorstandsvorsitzender | - |
Ausbildung von Yair Granot
University of California, Berkeley | Doctorate Degree |
Tel-Aviv University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SILVER CASTLE HOLDINGS LTD | Health Technology |
Private Unternehmen | 2 |
---|---|
Essence Healthcare Ltd. | |
Curesign Ltd
Curesign Ltd Medical SpecialtiesHealth Technology Curesign Ltd is a medical device company based in Tel Aviv, Israel. The Israeli company aims to revolutionize cancer treatment by integrating advanced sensors with signal processing and big data tools to create a patient-specific treatment plan for each cancer patient. The company's product is currently in advanced stages of development and has shown successful results in preclinical studies. The CEO of the company is Yair Granot. | Health Technology |